hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet
RxNorm concept 2649347, scdfp.
- RxCUI
- 2649347
- Term type
- SCDFP
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2649347 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet [Phosphasal] (SBDFP, has tradename)
- hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet [Urelle] (SBDFP, has tradename)
- hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet [Uretron DS] (SBDFP, has tradename)
- hyoscyamine sulfate / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet [Urimar Reformulated Oct 2013] (SBDFP, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2649347 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2649347 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2649347. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.